- Home
- VNRX vs SNAL Comparison
VNRX vs SNAL Comparison
Compare VNRX & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- SNAL
- Stock Information
- Founded
- VNRX N/A
- SNAL 2000
- Country
- VNRX United States
- SNAL United States
- Employees
- VNRX N/A
- SNAL N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SNAL Computer Software: Prepackaged Software
- Sector
- VNRX Health Care
- SNAL Technology
- Exchange
- VNRX Nasdaq
- SNAL Nasdaq
- Market Cap
- VNRX 52.4M
- SNAL 51.0M
- IPO Year
- VNRX N/A
- SNAL 2022
- Fundamental
- Price
- VNRX $0.66
- SNAL $1.40
- Analyst Decision
- VNRX Strong Buy
- SNAL
- Analyst Count
- VNRX 5
- SNAL 0
- Target Price
- VNRX $3.88
- SNAL N/A
- AVG Volume (30 Days)
- VNRX 319.2K
- SNAL 83.0K
- Earning Date
- VNRX 08-13-2025
- SNAL 08-12-2025
- Dividend Yield
- VNRX N/A
- SNAL N/A
- EPS Growth
- VNRX N/A
- SNAL N/A
- EPS
- VNRX N/A
- SNAL 0.04
- Revenue
- VNRX $1,308,361.00
- SNAL $90,462,190.00
- Revenue This Year
- VNRX $563.72
- SNAL $24.50
- Revenue Next Year
- VNRX $160.43
- SNAL $20.27
- P/E Ratio
- VNRX N/A
- SNAL $35.90
- Revenue Growth
- VNRX 64.16
- SNAL 46.95
- 52 Week Low
- VNRX $0.40
- SNAL $0.52
- 52 Week High
- VNRX $0.94
- SNAL $3.42
- Technical
- Relative Strength Index (RSI)
- VNRX 47.94
- SNAL 57.34
- Support Level
- VNRX $0.62
- SNAL $1.34
- Resistance Level
- VNRX $0.76
- SNAL $1.65
- Average True Range (ATR)
- VNRX 0.08
- SNAL 0.17
- MACD
- VNRX -0.02
- SNAL -0.00
- Stochastic Oscillator
- VNRX 12.47
- SNAL 36.21
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.